Fingerprint
Dive into the research topics of 'Regorafenib for the treatment of advanced gastric cancer (INTEGRATE): A multinational placebo-controlled phase II Trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Regorafenib for the treatment of advanced gastric cancer (INTEGRATE): A multinational placebo-controlled phase II Trial
Nick Pavlakis, Katrin M. Sjoquist, Andrew J. Martin, Eric Tsobanis, Sonia Yip, Yoon Koo Kang, Yung Jue Bang, Thierry Alcindor, Christopher J. O'Callaghan, Margot J. Burnell, Niall C. Tebbutt, Sun Young Rha, Jeeyun Lee, Jae Yong Cho, Lara R. Lipton, Mark Wong, Andrew Strickland, Jin Won Kim, John R. Zalcberg, John Simes
Research output: Contribution to journal › Article › peer-review
162
Citations
(Scopus)